Unknown

Dataset Information

0

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.


ABSTRACT:

Purpose

Mutation in isocitrate dehydrogenase 1 (IDH1) at R132 (IDH1(R132MUT)) is frequent in low-grade diffuse gliomas and, within glioblastoma (GBM), has been proposed as a marker for GBMs that arise by transformation from lower-grade gliomas, regardless of clinical history. To determine how GBMs arising with IDH1(R132MUT) differ from other GBMs, we undertook a comprehensive comparison of patients presenting clinically with primary GBM as a function of IDH1(R132) mutation status.

Patients and methods

In all, 618 treatment-naive primary GBMs and 235 lower-grade diffuse gliomas were sequenced for IDH1(R132) and analyzed for demographic, radiographic, anatomic, histologic, genomic, epigenetic, and transcriptional characteristics.

Results

Investigation revealed a constellation of features that distinguishes IDH1(R132MUT) GBMs from other GBMs (including frontal location and lesser extent of contrast enhancement and necrosis), relates them to lower-grade IDH1(R132MUT) gliomas, and supports the concept that IDH1(R132MUT) gliomas arise from a neural precursor population that is spatially and temporally restricted in the brain. The observed patterns of DNA sequence, methylation, and copy number alterations support a model of ordered molecular evolution of IDH1(R132MUT) GBM in which the appearance of mutant IDH1 protein is an initial event, followed by production of p53 mutant protein, and finally by copy number alterations of PTEN and EGFR.

Conclusion

Although histologically similar, GBMs arising with and without IDH1(R132MUT) appear to represent distinct disease entities that arise from separate cell types of origin as the result of largely nonoverlapping sets of molecular events. Optimal clinical management should account for the distinction between these GBM disease subtypes.

SUBMITTER: Lai A 

PROVIDER: S-EPMC3236649 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

Lai Albert A   Kharbanda Samir S   Pope Whitney B WB   Tran Anh A   Solis Orestes E OE   Peale Franklin F   Forrest William F WF   Pujara Kanan K   Carrillo Jose A JA   Pandita Ajay A   Ellingson Benjamin M BM   Bowers Chauncey W CW   Soriano Robert H RH   Schmidt Nils O NO   Mohan Sankar S   Yong William H WH   Seshagiri Somasekar S   Modrusan Zora Z   Jiang Zhaoshi Z   Aldape Kenneth D KD   Mischel Paul S PS   Liau Linda M LM   Escovedo Cameron J CJ   Chen Weidong W   Nghiemphu Phioanh Leia PL   James C David CD   Prados Michael D MD   Westphal Manfred M   Lamszus Katrin K   Cloughesy Timothy T   Phillips Heidi S HS  

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111024 34


<h4>Purpose</h4>Mutation in isocitrate dehydrogenase 1 (IDH1) at R132 (IDH1(R132MUT)) is frequent in low-grade diffuse gliomas and, within glioblastoma (GBM), has been proposed as a marker for GBMs that arise by transformation from lower-grade gliomas, regardless of clinical history. To determine how GBMs arising with IDH1(R132MUT) differ from other GBMs, we undertook a comprehensive comparison of patients presenting clinically with primary GBM as a function of IDH1(R132) mutation status.<h4>Pat  ...[more]

Similar Datasets

| S-EPMC6672028 | biostudies-literature
| S-EPMC1462305 | biostudies-other
| S-EPMC6368694 | biostudies-literature
| S-EPMC7546125 | biostudies-literature
| S-EPMC5865162 | biostudies-literature
| S-EPMC6966450 | biostudies-literature
| S-EPMC10516216 | biostudies-literature
| S-EPMC6995692 | biostudies-literature
| S-EPMC5629366 | biostudies-literature
| S-EPMC5640980 | biostudies-literature